학술논문
Overall survival with adjuvant atezolizumab after chemotherapy in resected stage II-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase III trial
Document Type
Article
Author
Source
In Annals of Oncology October 2023 34(10):907-919
Subject
Language
ISSN
0923-7534